Nilofer S. Azad

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 26 papers. Top paper: “Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers”.

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

Journal of Clinical Investigation(2021)10.1172/jci152670

N/A

2.1DataRank · unranked

86 citations

Leslie Cope, Amanda N. Ruggieri, Robert A. Anders, Anne M. Noonan, Laura W. Goff +24 more

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Science(2017)10.1126/science.aan6733

N/A

1.3DataRank · unranked

6550 citations

Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh +46 more

Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer

JCI Insight(2020)10.1172/jci.insight.136368

N/A

1.1DataRank · unranked

35 citations

Xingyi Pan, Kevin C. Soares, Nilofer S. Azad, Nita Ahuja, Christopher Gamper +6 more

Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial

Nature Communications(2024)10.1038/s41467-024-52528-7

N/A

1.0DataRank · unranked

42 citations

Ludmila Danilova, Jennifer N. Durham, Courtney B. Betts, Leslie Cope, Dimitrios N. Sidiropoulos +19 more

CD4 T cell–activating neoantigens enhance personalized cancer vaccine efficacy

JCI Insight(2023)10.1172/jci.insight.174027

N/A

0.921DataRank · unranked

34 citations

Gabriella Longway, Jacob T. Mitchell, Lalitya Andaloori, Emily F. Davis-Marcisak, Fangluo Chen +15 more

An analysis of genetic heterogeneity in untreated cancers

Nature Reviews Cancer(2019)10.1038/s41568-019-0185-x

N/A

0.805DataRank · unranked

213 citations

Marina Baretti, Jeffrey M. Gerold, Alvin P. Makohon-Moore, Adil Daud, Christine A. Iacobuzio–Donahue +5 more

High performance methylated DNA markers for detection of colon adenocarcinoma

Clinical Epigenetics(2021)10.1186/s13148-021-01206-2

N/A

0.470DataRank · unranked

22 citations

Abdul Hussain Vali, Jan N.M. IJzermans, Thomas R. Pisanic, Tza‐Huei Wang, Nilofer S. Azad +3 more

ETCTN 10476: A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps639

N/A

0.230DataRank · unranked

3 citations

Mark Yarchoan, Judy Murray, Hao Wang, John Joseph Wright, Elad Sharon +3 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488

N/A

0.111DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

Journal of Clinical Oncology(2022)10.1200/jco.21.02767

N/A

0DataRank · unranked

255 citations

Amber M. Johnson, Jeffrey Sklar, Neal I. Lindeman, Kathleen N. Moore, Shridar Ganesan +13 more

Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1123

N/A

0DataRank · unranked

13 citations

Mark Yarchoan, Subir Goyal, Yuan Liu, Elad Sharon, Helen X. Chen +7 more

Molecular predictors of response among patients with MMRd tumors treated on NCI-MATCH Arm Z1D.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2616

N/A

0DataRank · unranked

0 citations

Nilofer S. Azad, Jennifer Lee, Jacob P. K. Gross, Michael J. Overman, Katrina Kao +14 more

Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0458

N/A

0DataRank · unranked

109 citations

Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng +4 more

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps814

N/A

0DataRank · unranked

16 citations

Thatcher Heumann, Maureen Berg, Anna Ferguson, Su Jin Lim, Hao Wang +6 more

Spirituality in cancer patients on phase 1 clinical trials

Psycho-Oncology(2020)10.1002/pon.5380

N/A

0DataRank · unranked

23 citations

Vincent Chung, Marianna Koczywas, Tami Borneman, Terry L. Irish, Nora Ruel +4 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.23.550207

N/A

0DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future

The Lancet Oncology(2020)10.1016/s1470-2045(19)30795-8

N/A

0DataRank · unranked

241 citations

Elizabeth M. Jaffee, Nilofer S. Azad, Eric S. Christenson

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488.1

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0002

N/A

0DataRank · unranked

11 citations

Won Jin Ho, Daniel Shu, Jennifer N. Durham, Madelena Brancati, Heather Davis Bruning +23 more

Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia

JCI Insight(2025)10.1172/jci.insight.191595

N/A

0DataRank · unranked

10 citations

Jacob T. Mitchell, Sidharth Raghavan, Luciane T. Kagohara, Amanda L. Huff, Saurav D. Haldar +29 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2025)10.7554/elife.94488.3

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

A phase Ib study of a pooled synthetic long peptide mutant KRAS vaccine combined with balstilimab/botensilimab in metastatic pancreatic cancer and metastatic MMR-proficient colorectal cancer in the maintenance setting.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps2698

N/A

0DataRank · unranked

0 citations

Amanda L. Huff, Maureen Berg, Hao Wang, Julie M. Nauroth, Kyle Friedman +7 more

A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps758

N/A

0DataRank · unranked

11 citations

Carol Judkins, Anna Ferguson, Elizabeth Abou Diwan, Su Jin Lim, Hao Wang +7 more

A randomized trial of a palliative care intervention for patients on phase I studies.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12001

N/A

0DataRank · unranked

4 citations

Vincent Chung, Mark T. Hughes, Marianna Koczywas, Nilofer S. Azad, Louise Knight +4 more

Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2974

N/A

0DataRank · unranked

78 citations

Ding Ding, Barish H. Edil, Carol Judkins, Jennifer N. Durham, Dwayne L. Thomas +32 more

Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma

JCI Insight(2021)10.1172/jci.insight.138197

N/A

0DataRank · unranked

24 citations

Gilad Halpert, Michael G. Lerner, Hai‐Jie Hu, Peter Dimitrion, Matthew J. Weiss +17 more